- World rank, all time
- #17,840 of 42,892
- Rank in Germany
- #871 of 2,077
- Research works
- 149 ▼ 3% vs 2013–17
- Citations
- 4.5k 29.8 per fractional work
- Top-10% rate
- 16.1% record average 16.5%
- Open access
- 44% world 28%
What does Amgen (Germany) specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.4× the share of its output that it takes of world research.
- MedicineField · 20.4 works3.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.5×. Every wedge is a field page.
- Immunology and Microbiology 8.5×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Economics, Econometrics and Finance 1.5×
- Chemistry 1.2×
- Decision Sciences 0.7×
- Mathematics 0.6×
- Health Professions 0.5×
- Materials Science 0.3×
- Computer Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
Who are the top researchers at Amgen (Germany)?
Ranked on the composite score, Gerhard Zugmaier and Peter Kufer lead among researchers whose main affiliation is Amgen (Germany).
- 1 Gerhard Zugmaier Germany · #244,736 worldwide 122 citations · 26 works
- 2 Peter Kufer Germany · #587,993 worldwide 76 citations · 17 works
Which keywords describe research at Amgen (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Clinical Trials, Cancer Immunotherapy, Monoclonal Antibodies, Lymphoma, CAR T Cells, Chimeric Antigen Receptor and Glycosylation.
- Quality of Life
- Genetic Variants
- Genomic Profiling
- International Myeloma Working Group
- Staging System
- Prognostic Factors
- Fc Receptors
- Targeted Therapy
- Glycosylation
- CAR T Cells
- Monoclonal Antibodies
- Clinical Trials
- Immunotherapy
- Cancer Immunotherapy
- Lymphoma
- Chimeric Antigen Receptor
- Minimal Residual Disease
- Antibody Engineering
- Therapeutic Antibodies
- Biomarkers
- Diagnosis Criteria
- Chemotherapy
- Tumor Microenvironment
- Immunogenicity
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Immunotherapy4▲ 19×5 topics
- Clinical Trials4▲ 18×7 topics
- Cancer Immunotherapy3▲ 70×2 topics
- Monoclonal Antibodies3▲ 106×3 topics
- Lymphoma3▲ 57×2 topics
- CAR T Cells3▲ 118×1 topic
- Chimeric Antigen Receptor3▲ 118×1 topic
- Glycosylation3▲ 78×2 topics
- Minimal Residual Disease2▲ 114×2 topics
- Targeted Therapy2▲ 35×5 topics
- Antibody Engineering2▲ 126×1 topic
- Fc Receptors2▲ 126×1 topic
- Therapeutic Antibodies2▲ 102×2 topics
- Prognostic Factors2▲ 15×6 topics
- Biomarkers2▲ 8.2×4 topics
- Staging System2▲ 91×2 topics
- Diagnosis Criteria2▲ 155×1 topic
- International Myeloma Working Group2▲ 155×1 topic
- Chemotherapy2▲ 6.8×6 topics
- Genomic Profiling1▲ 43×2 topics
- Tumor Microenvironment1▲ 9.7×2 topics
- Genetic Variants1▲ 21×4 topics
- Immunogenicity1▲ 85×3 topics
- Quality of Life1▲ 2.2×4 topics
Which research topics does Amgen (Germany) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Multiple Myeloma Research and Treatments and Lung Cancer Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 3 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 3 Multiple Myeloma Research and Treatments Hematology 2 works
- 4 Lung Cancer Research Studies Oncology 1 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 7 Lipoproteins and Cardiovascular Health Surgery 1 works
- 8 Biosimilars and Bioanalytical Methods Immunology 1 works
- 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 10 Immunotherapy and Immune Responses Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Amgen (Germany)'s research output changed?
Output in 2018–2022 was 3% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Munich
- Ludwig-Maximilians-Universität München
- Max Planck Society
- Technical University of Munich
- Siemens (Germany)
- München Klinik
- LMU Klinikum
- Munich University of Applied Sciences
- TUM Klinikum
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.